0 votes
1 view
in Pharmaceutical Preparations by

Common limits for therapeutic application of peptides and proteins are their chemical instability, their short circulation time in blood and their tendency to promote immunological response. Linking one or more PEG (polyethylene glycol) molecules to these peptides and proteins (PEGylation) have been proven to be a possible solution for these problems. This is achieved due to the combination of increased molecular weight and coverage of epitopes or blockage of sequences prone to enzymatic degradation.

Your answer

Your name to display (optional):
Privacy: Your email address will only be used for sending these notifications.
Anti-spam verification:
To avoid this verification in future, please log in or register.
Welcome to lookformedical.com, where you can ask questions and receive answers from other members of the community.

3.7k questions

1.7k answers

110 comments

3.4k users

Disclaimer: We do not evaluate or guarantee the accuracy of any content in this site.
...